Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Piedmont Research Strategies (PRS) is a contract research organization (CRO) that provides specialized preclinical research services to the biotechnology and pharmaceutical industries. Based in North Carolina, the company focuses on in vivo pharmacology, particularly in the areas of oncology, immunology, and inflammation. PRS offers a comprehensive suite of services including efficacy studies, pharmacokinetic/pharmacodynamic (PK/PD) analysis, flow cytometry, and histology. By utilizing a variety of validated animal models and cell-based assays, the company assists clients in advancing therapeutic candidates from early discovery through the preclinical development phase. Their mission is to deliver high-quality, reproducible data to support critical decision-making in drug development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Piedmont Research Strategies.